NO325570B1 - Fremgangsmate ved krystallisering fra en lineaer eller forgrenet (C5-C6) alkohol eller deres blandinger av (S)-N,N'-bis[2-hydroksy-1-(hydroksymetyl)etyl]-5-[(2-hydroksy-1-oksopropyl)amino]-2,4,6-trijod-1,3-benzendikarboksamid - Google Patents
Fremgangsmate ved krystallisering fra en lineaer eller forgrenet (C5-C6) alkohol eller deres blandinger av (S)-N,N'-bis[2-hydroksy-1-(hydroksymetyl)etyl]-5-[(2-hydroksy-1-oksopropyl)amino]-2,4,6-trijod-1,3-benzendikarboksamid Download PDFInfo
- Publication number
- NO325570B1 NO325570B1 NO19993851A NO993851A NO325570B1 NO 325570 B1 NO325570 B1 NO 325570B1 NO 19993851 A NO19993851 A NO 19993851A NO 993851 A NO993851 A NO 993851A NO 325570 B1 NO325570 B1 NO 325570B1
- Authority
- NO
- Norway
- Prior art keywords
- solvent
- crystallization
- iopamidol
- pentanol
- mixture
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title claims abstract description 27
- 238000002425 crystallisation Methods 0.000 title claims abstract description 25
- 230000008025 crystallization Effects 0.000 title claims abstract description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title abstract 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 title abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1
- 239000002904 solvent Substances 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 claims description 26
- 229960004647 iopamidol Drugs 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 16
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 10
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 238000004821 distillation Methods 0.000 claims description 8
- JYVLIDXNZAXMDK-UHFFFAOYSA-N pentan-2-ol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 claims description 8
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims 3
- 238000005406 washing Methods 0.000 claims 3
- 238000001914 filtration Methods 0.000 claims 1
- 238000001291 vacuum drying Methods 0.000 claims 1
- -1 2-hydroxy-1-oxopropyl Chemical group 0.000 abstract description 3
- 239000000047 product Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 9
- 239000006227 byproduct Substances 0.000 description 6
- 239000013557 residual solvent Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 5
- 230000003134 recirculating effect Effects 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000001159 Fisher's combined probability test Methods 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB1997/000106 WO1998034908A1 (en) | 1997-02-11 | 1997-02-11 | PROCESS FOR THE CRYSTALLIZATION FROM A LINEAR OR BRANCHED (C5-C6) ALCOHOL OR THEIR MIXTURES OF (S)-N,N'-bis[2-HYDROXY-1- (HYDROXYMETHYL)ETHYL]-5-[ (2-HYDROXY-1-OXOPROPYl)AMINO]-2,4,6- TRIIODO-1,3-BENZENDICARBOXAMIDE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO993851D0 NO993851D0 (no) | 1999-08-10 |
| NO993851L NO993851L (no) | 1999-08-10 |
| NO325570B1 true NO325570B1 (no) | 2008-06-23 |
Family
ID=11004529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19993851A NO325570B1 (no) | 1997-02-11 | 1999-08-10 | Fremgangsmate ved krystallisering fra en lineaer eller forgrenet (C5-C6) alkohol eller deres blandinger av (S)-N,N'-bis[2-hydroksy-1-(hydroksymetyl)etyl]-5-[(2-hydroksy-1-oksopropyl)amino]-2,4,6-trijod-1,3-benzendikarboksamid |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6037494A (cs) |
| EP (1) | EP0966428B1 (cs) |
| JP (1) | JP4080545B2 (cs) |
| KR (1) | KR100758741B1 (cs) |
| AU (1) | AU1455397A (cs) |
| CZ (1) | CZ299420B6 (cs) |
| DE (2) | DE966428T1 (cs) |
| ES (1) | ES2141691T3 (cs) |
| NO (1) | NO325570B1 (cs) |
| WO (1) | WO1998034908A1 (cs) |
| ZA (1) | ZA981070B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0992245A1 (en) * | 1998-09-16 | 2000-04-12 | Goldham Bioglan Pharma GmbH | Radio-contrast agents |
| KR20000031642A (ko) * | 1998-11-09 | 2000-06-05 | 강재헌 | 이오파미돌의 결정화 방법 |
| NO20053676D0 (no) * | 2005-07-29 | 2005-07-29 | Amersham Health As | Crystallisation Process |
| NO20053687D0 (no) * | 2005-07-29 | 2005-07-29 | Amersham Health As | Crystallisation Process. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH608189A5 (cs) * | 1974-12-13 | 1978-12-29 | Savac Ag | |
| US5698739A (en) * | 1989-07-05 | 1997-12-16 | Schering Aktiengesellschaft | Carboxamide non-ionic contrast media |
| IL110391A (en) * | 1993-07-30 | 1998-12-06 | Zambon Spa | Process for the crystallization of iopamidol |
| PT101720A (pt) * | 1995-06-08 | 1997-01-31 | Hovione Sociedade Quimica S A | Processo para a purificacao e cristalizacao de iopamidol |
| WO1997002235A1 (en) * | 1995-07-04 | 1997-01-23 | Recordati S.A. Chemical And Pharmaceutical Company | A process for preparing iopamidol by using a c1-c5 monoalkylether of a c2-c10 alkylen-glycol |
-
1997
- 1997-02-11 EP EP97901229A patent/EP0966428B1/en not_active Expired - Lifetime
- 1997-02-11 JP JP53403098A patent/JP4080545B2/ja not_active Expired - Lifetime
- 1997-02-11 WO PCT/IB1997/000106 patent/WO1998034908A1/en active IP Right Grant
- 1997-02-11 CZ CZ0282599A patent/CZ299420B6/cs not_active IP Right Cessation
- 1997-02-11 KR KR1019997007191A patent/KR100758741B1/ko not_active Expired - Lifetime
- 1997-02-11 DE DE0966428T patent/DE966428T1/de active Pending
- 1997-02-11 ES ES97901229T patent/ES2141691T3/es not_active Expired - Lifetime
- 1997-02-11 DE DE69717156T patent/DE69717156T2/de not_active Expired - Lifetime
- 1997-02-11 AU AU14553/97A patent/AU1455397A/en not_active Abandoned
-
1998
- 1998-02-09 US US09/020,424 patent/US6037494A/en not_active Expired - Fee Related
- 1998-02-10 ZA ZA981070A patent/ZA981070B/xx unknown
-
1999
- 1999-08-10 NO NO19993851A patent/NO325570B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4080545B2 (ja) | 2008-04-23 |
| WO1998034908A1 (en) | 1998-08-13 |
| ES2141691T1 (es) | 2000-04-01 |
| CZ282599A3 (cs) | 2000-02-16 |
| NO993851D0 (no) | 1999-08-10 |
| KR20000070926A (ko) | 2000-11-25 |
| CZ299420B6 (cs) | 2008-07-23 |
| DE69717156T2 (de) | 2003-03-13 |
| KR100758741B1 (ko) | 2007-09-14 |
| AU1455397A (en) | 1998-08-26 |
| EP0966428B1 (en) | 2002-11-13 |
| DE69717156D1 (de) | 2002-12-19 |
| ZA981070B (en) | 1998-08-27 |
| US6037494A (en) | 2000-03-14 |
| ES2141691T3 (es) | 2003-05-16 |
| NO993851L (no) | 1999-08-10 |
| DE966428T1 (de) | 2000-06-29 |
| JP2001511175A (ja) | 2001-08-07 |
| EP0966428A1 (en) | 1999-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7181896B2 (ja) | オメカムティブメカルビルの合成 | |
| US6506938B1 (en) | Process for the purifying of iopamidol | |
| NO325570B1 (no) | Fremgangsmate ved krystallisering fra en lineaer eller forgrenet (C5-C6) alkohol eller deres blandinger av (S)-N,N'-bis[2-hydroksy-1-(hydroksymetyl)etyl]-5-[(2-hydroksy-1-oksopropyl)amino]-2,4,6-trijod-1,3-benzendikarboksamid | |
| US5041655A (en) | Method of preparing 1,6-di(N3 -cyano-N1 -guanidino) hexane | |
| DE69631169T2 (de) | Herstellung von (s)-decahydroisochinolin-3-carbonsäure-t-butylamid | |
| KR20230004724A (ko) | 프탈라지논 유도체 및 이의 중간체의 제조 방법 | |
| US7642279B2 (en) | Atipamezole hydrochloride crystallization method | |
| CN104817546B (zh) | 一种奥美沙坦酯母液回收的方法 | |
| US6521792B2 (en) | Process for separating the diastereomeric bases of 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cylohexanol | |
| US7728147B2 (en) | Detomidine hydrochloride crystallization method | |
| EP3474847B1 (en) | Processes for the preparation of eluxadoline | |
| EP4183450B1 (en) | Method for preparing a hydrated form of perindopril l-arginine | |
| CN106316985B (zh) | 一种β型高效氢溴酸沃替西汀转晶方法 | |
| RU2741389C1 (ru) | Способ получения промежуточного соединения для синтеза лекарственного средства | |
| DE602004002473T2 (de) | Herstellung von quinapril hydrochlorid | |
| CN109879739A (zh) | 一种对苯二甲醛的精制方法 | |
| NO125095B (cs) | ||
| CN117843716A (zh) | 一种卡非佐米的精制方法 | |
| CN115991673A (zh) | 一种瑞戈非尼的纯化方法 | |
| EP1070083A1 (fr) | Formes cristallines du 1s-[1alpha(2s*,3r*),9alpha]-6,10-dioxo-n- (2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl)carbonyl]- amino]octahydro-6h-piridazino[1,2-a][1,2]diazepine-1-carboxamide | |
| JPH06135918A (ja) | Ｎ，ｏ−ジアルキルヒドロキシルアミン塩酸塩の分離 方法 | |
| NO331657B1 (no) | Fremgangsmate for fremstilling av iohexol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |